Search

everythinglearnresearchcommunity

for

Search:↓

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Early recognition and treatment of Peripheral Arterial Disease is crucial to improve survival and health outcomes.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

Black patients with a specific type of hair loss have a much higher chance of lacking enough vitamin D.

DCPA is a chronic leg infection often related to Staphylococcus aureus, affecting mostly young men in India.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

PAD is common but often missed, needing lifestyle changes and medication for better outcomes.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

Men with CCCA often face delayed diagnosis and severe hair loss, highlighting the need for earlier recognition and treatment.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

CD2 might be a new treatment target for patchy alopecia areata.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Black women with CCCA are more likely to have uterine fibroids.

Diagonal earlobe crease and lipoprotein(a) together help diagnose coronary heart disease.

Cadd4 effectively reduces cholesterol levels without side effects.

HDPCM treatment healed a baby's congenital skin defect caused by varicella infection.

Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

The AAcQLI is a promising tool for assessing quality of life in children with alopecia areata.

Middle-aged women with dilated cardiomyopathy should be screened for antiphospholipid syndrome.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.